Abstract
A total of 87 patients (17 female, 70 male) were admitted to Siriraj Hospital, Mahidol University, Bangkok, Thailand, from January 1996 to December 1997, with a diagnosis of cryptococcal meningitis and underlying AIDS. The age range was 14-70 years, mean 32.1. Six females (35%) and thirty-one males (44%) died, while the others were discharged home after clinical improvement. The mean duration of admission of those who died was 14.5 days, which was shorter than that of the patients who survived (25.7 days). Cerebral cryptococcosis was diagnosed using culture (100%), India ink preparation (91%), latex agglutination test (100%), and polymerase chain reaction (86%). Polymerase chain reaction fingerprinting of Cryptococcus neoformans revealed 99% serotype A and 1% serotype B. The mean minimum inhibitory concentrations of amphotericin B, flucytosine, fluconazole and itraconazole against 87 isolates of C neoformans were 0.55 µg/ml (0.25-1, SD = 0.22), 9.5 µg/ml (2-20, SD = 4.91), 6.9 µg/ml (1-16, SD = 4.42) and 0.36 µg/ml (0.125-1.0, SD = 0.23), respectively. These findings showed that the cryptococcal infections were sensitive to these antifungal agents. Keywords: Cryptococcus neoformans; AIDS; polymerase chain reaction fingerprinting; antifungal agents
Full Text
The Full Text of this article is available as a PDF (894.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anaissie E., Shawar R., Paetznick V., Ensign L. G., Witte Z., LaRocco M. Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media. J Clin Microbiol. 1993 May;31(5):1370–1372. doi: 10.1128/jcm.31.5.1370-1372.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barchiesi F., Colombo A. L., McGough D. A., Rinaldi M. G. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J Clin Microbiol. 1994 Oct;32(10):2494–2500. doi: 10.1128/jcm.32.10.2494-2500.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghannoum M. A., Fu Y., Ibrahim A. S., Mortara L. A., Shafiq M. C., Edwards J. E., Jr, Criddle R. S. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother. 1995 Nov;39(11):2459–2465. doi: 10.1128/aac.39.11.2459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Imwidthaya P., Dithaprasop P., Egtasaeng C. Clinical and environmental isolates of Cryptococcus neoformans in Bangkok (Thailand). Mycopathologia. 1989 Oct;108(1):65–67. doi: 10.1007/BF00436786. [DOI] [PubMed] [Google Scholar]
- Imwidthaya P., Egtasaeng C. Latex agglutination test for diagnosing cryptococcosis. J Med Assoc Thai. 1991 Oct;74(10):454–458. [PubMed] [Google Scholar]
- Kwon-Chung K. J., Bennett J. E. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984 Jul;120(1):123–130. doi: 10.1093/oxfordjournals.aje.a113861. [DOI] [PubMed] [Google Scholar]
- Meyer W., Mitchell T. G., Freedman E. Z., Vilgalys R. Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J Clin Microbiol. 1993 Sep;31(9):2274–2280. doi: 10.1128/jcm.31.9.2274-2280.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poonwan N., Mikami Y., Poosuwan S., Boon-Long J., Mekha N., Kusum M., Yazawa K., Tanaka R., Nishimura K., Konyama K. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol. 1997 Apr;13(3):335–340. doi: 10.1023/a:1007376917836. [DOI] [PubMed] [Google Scholar]
- Prariyachatigul C., Chaiprasert A., Meevootisom V., Pattanakitsakul S. Assessment of a PCR technique for the detection and identification of Cryptococcus neoformans. J Med Vet Mycol. 1996 Jul-Aug;34(4):251–258. doi: 10.1080/02681219680000431. [DOI] [PubMed] [Google Scholar]
- Salkin I. F., Hurd N. J. New medium for differentiation of Cryptococcus neoformans serotype pairs. J Clin Microbiol. 1982 Jan;15(1):169–171. doi: 10.1128/jcm.15.1.169-171.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seaton R. A., Verma N., Naraqi S., Wembri J. P., Warrell D. A. Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):44–49. doi: 10.1016/s0035-9203(97)90391-6. [DOI] [PubMed] [Google Scholar]
- Tanaka K., Kohno S., Miyazaki T., Miyazaki H., Mitsutake K., Maesaki S., Kaku M., Koga H. The Eiken Latex test for detection of a cryptococcal antigen in cryptococcosis. Comparison with a monoclonal antibody-based latex agglutination test, Pastorex Cryptococcus. Mycopathologia. 1994 Sep;127(3):131–134. doi: 10.1007/BF01102911. [DOI] [PubMed] [Google Scholar]
- Tortorano A. M., Viviani M. A., Rigoni A. L., Cogliati M., Roverselli A., Pagano A. Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses. 1997 Nov;40(7-8):297–302. doi: 10.1111/j.1439-0507.1997.tb00235.x. [DOI] [PubMed] [Google Scholar]
- Viviani M. A., Wen H., Roverselli A., Caldarelli-Stefano R., Cogliati M., Ferrante P., Tortorano A. M. Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD. J Med Vet Mycol. 1997 Sep-Oct;35(5):355–360. [PubMed] [Google Scholar]
- Wu J., Liao W., Chai J. Isolation of specific DNA probes for detection of Cryptococcus neoformans. Mycoses. 1997 Dec;40(9-10):385–389. doi: 10.1111/j.1439-0507.1997.tb00256.x. [DOI] [PubMed] [Google Scholar]
